• linkedin
  • Increase Font
  • Sharebar

    Health apps beneficial to help prevent COPD exacerbation

    Early intervention is key to managing chronic obstructive pulmonary disease (COPD), and a new report out of Temple Lung Center in Philadelphia details the successes of telemedicine in heading off acute exacerbations.

    COPD is the third leading cause of death in the United States, causing more than 130,000 deaths each year, according to the American Lung Association. Roughly 12.7 million Americans have been diagnosed with the chronic respiratory disease, which presents with increasing coughing, sputum, and dyspnea. Acute exacerbations of the disease often result in hospitalization, adding to the already high costs to manage the condition. COPD costs about $49.9 billion annually, including $29.5 billion in direct healthcare costs.

    Related: Prescribing mobile apps: What to consider

    But in the two-year clinical study led by Gerard J. Criner, MD, FACP, FACCP, founding chair of the new department of thoracic medicine and surgery at Temple University School of Medicine, and director of the Temple Lung Center, researchers found that patients that used a digital health application to report their daily symptoms and received same-day treatment recommendations from their health care provider experienced fewer and less severe COPD exacerbation symptoms, leading to an improvement in daily symptom control, lung function, and activity levels.

     

    NEXT: Digital symptom reporting allows for patinet-specific treatment

    Rachael Zimlich, RN
    Ms Zimlich is a freelance writer in Cleveland, Ohio. She writes regularly for Contemporary Pediatrics, Managed Healthcare Executive, and ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow